1
|
Tanjung AP, Yin K, Zhao L, Wu JZ, Wang AJ, Mei LP, Song P, Feng JJ. Target-regulated photoactivities of CdS/Ni-MOF heterojunction with [Ru(bpy) 2dppz] 2+ intercalator: a bisphenol A photoelectrochemical aptasensor. Mikrochim Acta 2024; 191:139. [PMID: 38360951 DOI: 10.1007/s00604-024-06230-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2023] [Accepted: 01/23/2024] [Indexed: 02/17/2024]
Abstract
Bisphenol A (BPA), an important endocrine disrupting compound, has infiltrated human daily lives through electronic devices, food containers, and children's toys. Developing of novel BPA assay methods with high sensitivity holds tremendous importance in valuing the pollution state. Here, we constructed an ultrasensitive photoelectrochemical (PEC) aptasensor for BPA determination by regulating photoactivities of CdS/Ni-based metal-organic framework (CdS/Ni-MOF) with [Ru(bpy)2dppz]2+ sensitizer. CdS/Ni-MOF spheres exhibited excellent photocatalytic performance, serving as a potential sensing platform for the construction of target recognition process. [Ru(bpy)2dppz]2+ were embedded into DNA double-stranded structure, functioning as sensitizer for modulating the signal response of the developed PEC aptasensor. The proposed PEC sensor exhibited outstanding analytical performances, including a wide linear range (0.1 to 1000.0 nM), low detection limit (0.026 nM, at 3σ/m), excellent selectivity, and high stability. This work provides a perspective for the design of ideal photosensitive materials and signal amplification strategies and extends their application in environment analysis.
Collapse
Affiliation(s)
- Aisyah Protonia Tanjung
- College of Geography and Environmental Sciences, Key Laboratory of Watershed Earth Surface Processes and Ecological Security, College of Chemistry and Materials Sciences, Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Zhejiang Normal University, Jinhua, 321004, China
| | - Ke Yin
- College of Geography and Environmental Sciences, Key Laboratory of Watershed Earth Surface Processes and Ecological Security, College of Chemistry and Materials Sciences, Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Zhejiang Normal University, Jinhua, 321004, China
| | - Lei Zhao
- College of Geography and Environmental Sciences, Key Laboratory of Watershed Earth Surface Processes and Ecological Security, College of Chemistry and Materials Sciences, Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Zhejiang Normal University, Jinhua, 321004, China
| | - Jiang-Zhou Wu
- College of Geography and Environmental Sciences, Key Laboratory of Watershed Earth Surface Processes and Ecological Security, College of Chemistry and Materials Sciences, Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Zhejiang Normal University, Jinhua, 321004, China
| | - Ai-Jun Wang
- College of Geography and Environmental Sciences, Key Laboratory of Watershed Earth Surface Processes and Ecological Security, College of Chemistry and Materials Sciences, Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Zhejiang Normal University, Jinhua, 321004, China
| | - Li-Ping Mei
- College of Geography and Environmental Sciences, Key Laboratory of Watershed Earth Surface Processes and Ecological Security, College of Chemistry and Materials Sciences, Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Zhejiang Normal University, Jinhua, 321004, China.
| | - Pei Song
- College of Geography and Environmental Sciences, Key Laboratory of Watershed Earth Surface Processes and Ecological Security, College of Chemistry and Materials Sciences, Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Zhejiang Normal University, Jinhua, 321004, China.
- Central Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, China.
| | - Jiu-Ju Feng
- College of Geography and Environmental Sciences, Key Laboratory of Watershed Earth Surface Processes and Ecological Security, College of Chemistry and Materials Sciences, Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Zhejiang Normal University, Jinhua, 321004, China.
| |
Collapse
|
2
|
Liu Y, Li Y, Hang Y, Wang L, Wang J, Bao N, Kim Y, Jang HW. Rapid assays of SARS-CoV-2 virus and noble biosensors by nanomaterials. NANO CONVERGENCE 2024; 11:2. [PMID: 38190075 PMCID: PMC10774473 DOI: 10.1186/s40580-023-00408-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/16/2023] [Accepted: 12/07/2023] [Indexed: 01/09/2024]
Abstract
The COVID-19 outbreak caused by SARS-CoV-2 in late 2019 has spread rapidly across the world to form a global epidemic of respiratory infectious diseases. Increased investigations on diagnostic tools are currently implemented to assist rapid identification of the virus because mass and rapid diagnosis might be the best way to prevent the outbreak of the virus. This critical review discusses the detection principles, fabrication techniques, and applications on the rapid detection of SARS-CoV-2 with three categories: rapid nuclear acid augmentation test, rapid immunoassay test and biosensors. Special efforts were put on enhancement of nanomaterials on biosensors for rapid, sensitive, and low-cost diagnostics of SARS-CoV-2 virus. Future developments are suggested regarding potential candidates in hospitals, clinics and laboratories for control and prevention of large-scale epidemic.
Collapse
Affiliation(s)
- Yang Liu
- School of Public Health, Nantong University, Nantong, 226019, Jiangsu, People's Republic of China
- Department of Materials Science and Engineering, Research Institute of Advanced Materials, Seoul National University, Seoul, 08826, Republic of Korea
- NantongEgens Biotechnology Co., LTD, Nantong, 226019, Jiangsu, People's Republic of China
| | - Yilong Li
- School of Public Health, Nantong University, Nantong, 226019, Jiangsu, People's Republic of China
| | - Yuteng Hang
- School of Public Health, Nantong University, Nantong, 226019, Jiangsu, People's Republic of China
| | - Lei Wang
- NantongEgens Biotechnology Co., LTD, Nantong, 226019, Jiangsu, People's Republic of China
| | - Jinghan Wang
- Department of Materials Science and Engineering, Research Institute of Advanced Materials, Seoul National University, Seoul, 08826, Republic of Korea
| | - Ning Bao
- School of Public Health, Nantong University, Nantong, 226019, Jiangsu, People's Republic of China
| | - Youngeun Kim
- Department of Materials Science and Engineering, Research Institute of Advanced Materials, Seoul National University, Seoul, 08826, Republic of Korea.
| | - Ho Won Jang
- Department of Materials Science and Engineering, Research Institute of Advanced Materials, Seoul National University, Seoul, 08826, Republic of Korea.
| |
Collapse
|
3
|
Tian B, Wang Y, Tang W, Chen J, Zhang J, Xue S, Zheng S, Cheng G, Gu B, Chen M. Tandem CRISPR nucleases-based lateral flow assay for amplification-free miRNA detection via the designed "locked RNA/DNA" as fuels. Talanta 2024; 266:124995. [PMID: 37524043 DOI: 10.1016/j.talanta.2023.124995] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2023] [Revised: 06/28/2023] [Accepted: 07/25/2023] [Indexed: 08/02/2023]
Abstract
Currently, available biosensors based on CRISPR/Cas typically depend on coupling with nucleic acid amplification technologies to enhance their sensitivity. However, this approach often involves intricate amplification processes, which could be time-consuming and susceptible to contamination. In addition, signal readouts often require sophisticated and cumbersome equipment, obstructing the applicability of CRISPR/Cas assays in resource-limited regions. Herein, a tandem CRISPR/Cas13a/Cas12a mechanism (tanCRISPR) has been developed via the designed "Locked RNA/DNA" probe as fuels for the trans-cleavage nucleic acid of Cas13a and activated nucleic acid of Cas12a. Meanwhile, a lateral flow assay (LFA) is designed to combine with this tandem CRISPR/Cas13a/Cas12a mechanism (termed tanCRISPR-LFA), realizing the portable monitoring of miRNA-21. The tanCRISPR could realize the limit of detection at pM levels (266 folds lower than Cas13a-based miRNA testing alone) without the resort to target amplification procedures. Furthermore, the miRNA-21 levels of MDA-MB-231 cell extracts are sensed by tanCRISPR-LFA, which is comparable to qRT-PCR. With the virtues of portability, rapidity, sensitivity, and low cost, tanCRISPR-LFA is amenable for CRISPR/Cas-based biosensing and potential applications in the clinical diagnosis of miRNA-associated diseases.
Collapse
Affiliation(s)
- Benshun Tian
- Medical Technology School, Xuzhou Medical University, Xuzhou, 221006, China; Department of Clinical Laboratory Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, 510000, China
| | - Yuxin Wang
- School of Medical Imaging, Xuzhou Medical University, Xuzhou, 221006, China
| | - Wuyue Tang
- School of Medical Imaging, Xuzhou Medical University, Xuzhou, 221006, China
| | - Jiali Chen
- School of Medical Imaging, Xuzhou Medical University, Xuzhou, 221006, China
| | - Jingwen Zhang
- School of Medical Imaging, Xuzhou Medical University, Xuzhou, 221006, China
| | - Siyi Xue
- School of Medical Imaging, Xuzhou Medical University, Xuzhou, 221006, China
| | - Shaohui Zheng
- School of Medical Imaging, Xuzhou Medical University, Xuzhou, 221006, China
| | - Guohui Cheng
- School of Pharmacy, Xuzhou Medical University, Xuzhou, 221006, China.
| | - Bing Gu
- Medical Technology School, Xuzhou Medical University, Xuzhou, 221006, China; Department of Clinical Laboratory Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, 510000, China.
| | - Minghui Chen
- School of Medical Imaging, Xuzhou Medical University, Xuzhou, 221006, China.
| |
Collapse
|
4
|
Akalın P, Yazgan-Karataş A. Development of a nucleic acid-based lateral flow device as a reliable diagnostic tool for respiratory viral infections. MethodsX 2023; 11:102372. [PMID: 37744884 PMCID: PMC10511794 DOI: 10.1016/j.mex.2023.102372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2023] [Accepted: 09/08/2023] [Indexed: 09/26/2023] Open
Abstract
Viral infections continue to pose a significant threat to the public health, leading to high morbidity and mortality rates worldwide. To combat these challenges, early detection and treatment are essential in reducing hospitalizations and preventing severe complications. Simple, inexpensive, and sensitive diagnostic methods are in constant demand in many areas. In this study, we report the development of a nucleic acid-based lateral flow immunoassay device (NALFIA) and demonstrate its successful application in conjunction with a multiplexed reverse-transcription loop-mediated isothermal amplification assay (LAMP) for the detection of SARS-CoV-2 and influenza. In our approach the NALFIA part preparation is independent of the target, and has the potential to ensure widespread use in diagnostics particularly where testing speed is critical such as in respiratory viral infections.•Simple, inexpensive, sensitive and reliable rapid diagnostic tool.•Target independent design.•Effective use for respiratory samples due to practical sample extraction.
Collapse
Affiliation(s)
- Pınar Akalın
- Dr. Orhan Öcalgiray Molecular Biology, Biotechnology and Genetics Research Center (ITU-MOBGAM), Istanbul Technical University, Maslak 34469, Istanbul, Turkey
| | - Ayten Yazgan-Karataş
- Dr. Orhan Öcalgiray Molecular Biology, Biotechnology and Genetics Research Center (ITU-MOBGAM), Istanbul Technical University, Maslak 34469, Istanbul, Turkey
- Faculty of Science and Letters, Department of Molecular Biology and Genetics, Istanbul Technical University, Maslak 34469 Istanbul, Turkey
| |
Collapse
|
5
|
Srinivasan Rajsri K, McRae MP, Christodoulides NJ, Dapkins I, Simmons GW, Matz H, Dooley H, Fenyö D, McDevitt JT. Simultaneous Quantitative SARS-CoV-2 Antigen and Host Antibody Detection and Pre-Screening Strategy at the Point of Care. Bioengineering (Basel) 2023; 10:670. [PMID: 37370601 PMCID: PMC10295356 DOI: 10.3390/bioengineering10060670] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Revised: 05/16/2023] [Accepted: 05/25/2023] [Indexed: 06/29/2023] Open
Abstract
As COVID-19 pandemic public health measures are easing globally, the emergence of new SARS-CoV-2 strains continue to present high risk for vulnerable populations. The antibody-mediated protection acquired from vaccination and/or infection is seen to wane over time and the immunocompromised populations can no longer expect benefit from monoclonal antibody prophylaxis. Hence, there is a need to monitor new variants and its effect on vaccine performance. In this context, surveillance of new SARS-CoV-2 infections and serology testing are gaining consensus for use as screening methods, especially for at-risk groups. Here, we described an improved COVID-19 screening strategy, comprising predictive algorithms and concurrent, rapid, accurate, and quantitative SARS-CoV-2 antigen and host antibody testing strategy, at point of care (POC). We conducted a retrospective analysis of 2553 pre- and asymptomatic patients who were tested for SARS-CoV-2 by RT-PCR. The pre-screening model had an AUC (CI) of 0.76 (0.73-0.78). Despite being the default method for screening, body temperature had lower AUC (0.52 [0.49-0.55]) compared to case incidence rate (0.65 [0.62-0.68]). POC assays for SARS-CoV-2 nucleocapsid protein (NP) and spike (S) receptor binding domain (RBD) IgG antibody showed promising preliminary results, demonstrating a convenient, rapid (<20 min), quantitative, and sensitive (ng/mL) antigen/antibody assay. This integrated pre-screening model and simultaneous antigen/antibody approach may significantly improve accuracy of COVID-19 infection and host immunity screening, helping address unmet needs for monitoring vaccine effectiveness and severe disease surveillance.
Collapse
Affiliation(s)
- Kritika Srinivasan Rajsri
- Division of Biomaterials, Department of Molecular Pathobiology, New York University School of Dentistry, New York, NY 10010, USA; (K.S.R.); (M.P.M.); (N.J.C.); (G.W.S.)
- Department of Pathology, Vilcek Institute of Graduate Biomedical Sciences, New York University School of Medicine, New York, NY 10010, USA
| | - Michael P. McRae
- Division of Biomaterials, Department of Molecular Pathobiology, New York University School of Dentistry, New York, NY 10010, USA; (K.S.R.); (M.P.M.); (N.J.C.); (G.W.S.)
| | - Nicolaos J. Christodoulides
- Division of Biomaterials, Department of Molecular Pathobiology, New York University School of Dentistry, New York, NY 10010, USA; (K.S.R.); (M.P.M.); (N.J.C.); (G.W.S.)
| | - Isaac Dapkins
- Departments of Population Health and Medicine, New York University School of Medicine, New York, NY 10010, USA;
| | - Glennon W. Simmons
- Division of Biomaterials, Department of Molecular Pathobiology, New York University School of Dentistry, New York, NY 10010, USA; (K.S.R.); (M.P.M.); (N.J.C.); (G.W.S.)
| | - Hanover Matz
- Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; (H.M.); (H.D.)
| | - Helen Dooley
- Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; (H.M.); (H.D.)
| | - David Fenyö
- Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10010, USA;
| | - John T. McDevitt
- Division of Biomaterials, Department of Molecular Pathobiology, New York University School of Dentistry, New York, NY 10010, USA; (K.S.R.); (M.P.M.); (N.J.C.); (G.W.S.)
| |
Collapse
|
6
|
Khumngern S, Jeerapan I. Advances in wearable electrochemical antibody-based sensors for cortisol sensing. Anal Bioanal Chem 2023:10.1007/s00216-023-04577-y. [PMID: 36781449 DOI: 10.1007/s00216-023-04577-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2022] [Revised: 01/26/2023] [Accepted: 01/30/2023] [Indexed: 02/15/2023]
Abstract
Cortisol is a crucial hormone involving many physiological processes. Hence, cortisol detection is essential. This review highlights the key progress made on wearable electrochemical sensors using antibodies. It covers the design, principle, and electroanalytical methodology for detecting cortisol noninvasively. This article also analyzes and collects the analytical performances of electrochemical cortisol sensors. The development of these sensors continues to face challenges such as biofouling, sample management, sensitivity, flexibility, stability, and recognition layer performance. It is also necessary to develop a sensitive electrode and material. This article also presents potential strategies for designing antibody electrodes and provides examples of sensing systems. Additionally, it discusses the challenges in translating research into practical applications.
Collapse
Affiliation(s)
- Suntisak Khumngern
- Division of Physical Science, Faculty of Science, Prince of Songkla University, Hat Yai, 90110, Songkhla, Thailand.,Center of Excellence for Trace Analysis and Biosensor, Prince of Songkla University, Hat Yai, 90110, Songkhla, Thailand
| | - Itthipon Jeerapan
- Division of Physical Science, Faculty of Science, Prince of Songkla University, Hat Yai, 90110, Songkhla, Thailand. .,Center of Excellence for Trace Analysis and Biosensor, Prince of Songkla University, Hat Yai, 90110, Songkhla, Thailand. .,Center of Excellence for Innovation in Chemistry, Faculty of Science, Prince of Songkla University, Hat Yai, 90110, Songkhla, Thailand.
| |
Collapse
|
7
|
He Z, Liu C, Li Z, Chu Z, Chen X, Chen X, Guo Y. Advances in the use of nanomaterials for nucleic acid detection in point-of-care testing devices: A review. Front Bioeng Biotechnol 2022; 10:1020444. [DOI: 10.3389/fbioe.2022.1020444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2022] [Accepted: 09/23/2022] [Indexed: 01/03/2023] Open
Abstract
The outbreak of the coronavirus (COVID-19) has heightened awareness of the importance of quick and easy testing. The convenience, speed, and timely results from point-of-care testing (POCT) in all vitro diagnostic devices has drawn the strong interest of researchers. However, there are still many challenges in the development of POCT devices, such as the pretreatment of samples, detection sensitivity, specificity, and so on. It is anticipated that the unique properties of nanomaterials, e.g., their magnetic, optical, thermal, and electrically conductive features, will address the deficiencies that currently exist in POCT devices. In this review, we mainly analyze the work processes of POCT devices, especially in nucleic acid detection, and summarize how novel nanomaterials used in various aspects of POCT products can improve performance, with the ultimate aims of offering new ideas for the application of nanomaterials and the overall development of POCT devices.
Collapse
|
8
|
Comparison of a Blood Self-Collection System with Routine Phlebotomy for SARS-CoV-2 Antibody Testing. Diagnostics (Basel) 2022; 12:diagnostics12081857. [PMID: 36010206 PMCID: PMC9406345 DOI: 10.3390/diagnostics12081857] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Revised: 07/26/2022] [Accepted: 07/28/2022] [Indexed: 12/02/2022] Open
Abstract
The Coronavirus Disease 2019 (COVID-19) pandemic forced researchers to reconsider in-person assessments due to transmission risk. We conducted a pilot study to evaluate the feasibility of using the Tasso-SST (Tasso, Inc, Seattle, Washington) device for blood self-collection for use in SARS-CoV-2 antibody testing in an ongoing COVID-19 prevalence and immunity research study. 100 participants were recruited between January and March 2021 from a previously identified sub-cohort of the Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study who were under-going bimonthly COVID-19 antibody testing. Participants were given a Tasso-SST kit and asked to self-collect blood during a scheduled visit where trained laboratory personnel performed routine phlebotomy. All participants completed an after-visit survey about their experience. Overall, 70.0% of participants were able to collect an adequate sample for testing using the device. Among those with an adequate sample, there was a high concordance in results between the Tasso-SST and phlebotomy blood collection methods (Cohen’s kappa coefficient = 0.88, Interclass correlation coefficient 0.98 [0.97, 0.99], p < 0.0001). The device received a high-level (90.0%) of acceptance among all participants. Overall, the Tasso-SST could prove to be a valuable tool for seroprevalence testing. However, future studies in larger, diverse populations over longer periods may provide a better understanding of device usability and acceptance among older participants and those with comorbidities in various use scenarios.
Collapse
|
9
|
Zhao T, Yan W, Dong F, Hu X, Xu Y, Wang Z, Shen Y, Wang W, Zhao Y, Wei W. A smartphone-based platform for ratiometric visualization of SARS-CoV-2 via an oligonucleotide probe. Mikrochim Acta 2022; 189:268. [PMID: 35781842 DOI: 10.1007/s00604-022-05364-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2022] [Accepted: 05/31/2022] [Indexed: 10/17/2022]
Abstract
COVID-19 necessitates the development of reliable and convenient diagnostic tools. In this work, a facile 3D-printed smartphone platform was constructed that achieved reliable visual detection of SARS-CoV-2 by eliminating the effect of ambient light and fixing the camera position relative to the sample. The oligonucleotide probe is modified with orange-red-emitting TAMRA working as an internal standard and green-emitting FAM serving as a sensitive sensing agent. Under 365-nm UV excitation, the emission wavelengths of TAMRA and FAM are 580 nm and 518 nm, respectively. When the probes interact with the targets, the green fluorescence gradually restores while the orange-red fluorescence remains stable. Thus, a striking color transition from orange-red to green could be observed by the naked eye. The detection limit of SARS-CoV-2 nucleic acid is 0.23 nM, and the entire process of color change could be completed in 25 min. Furthermore, the RGB value analysis of the sample solution was conducted using a smartphone for reliable and reproducible discrimination of SARS-CoV-2. The proposed smartphone platform might establish a general method for visual detection of SARS-CoV-2 nucleic acid as well as other virus-related diseases.
Collapse
Affiliation(s)
- Tingting Zhao
- School of Basic Medical Sciences, Biopharmaceutical Research Institute, Research and Engineering Center of Biomedical Materials, Anhui Medical University, Hefei, 230032, Anhui, China.
| | - Weizhen Yan
- The First School of Clinical Medicine, Anhui Medical University, Hefei, 230032, Anhui, China
| | - Fengqi Dong
- School of Basic Medical Sciences, Biopharmaceutical Research Institute, Research and Engineering Center of Biomedical Materials, Anhui Medical University, Hefei, 230032, Anhui, China
| | - Xinlong Hu
- School of Basic Medical Sciences, Biopharmaceutical Research Institute, Research and Engineering Center of Biomedical Materials, Anhui Medical University, Hefei, 230032, Anhui, China
| | - Yanli Xu
- School of Basic Medical Sciences, Biopharmaceutical Research Institute, Research and Engineering Center of Biomedical Materials, Anhui Medical University, Hefei, 230032, Anhui, China
| | - Zhenyu Wang
- The First School of Clinical Medicine, Anhui Medical University, Hefei, 230032, Anhui, China
| | - Yating Shen
- The First School of Clinical Medicine, Anhui Medical University, Hefei, 230032, Anhui, China
| | - Wanrong Wang
- The First School of Clinical Medicine, Anhui Medical University, Hefei, 230032, Anhui, China
| | - Ye Zhao
- School of Basic Medical Sciences, Biopharmaceutical Research Institute, Research and Engineering Center of Biomedical Materials, Anhui Medical University, Hefei, 230032, Anhui, China.
| | - Wenmei Wei
- School of Basic Medical Sciences, Biopharmaceutical Research Institute, Research and Engineering Center of Biomedical Materials, Anhui Medical University, Hefei, 230032, Anhui, China.
| |
Collapse
|
10
|
Xue Y, Chen Z, Zhang W, Zhang J. Engineering CRISPR/Cas13 System against RNA Viruses: From Diagnostics to Therapeutics. Bioengineering (Basel) 2022; 9:bioengineering9070291. [PMID: 35877342 PMCID: PMC9312194 DOI: 10.3390/bioengineering9070291] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Revised: 06/22/2022] [Accepted: 06/27/2022] [Indexed: 12/23/2022] Open
Abstract
Over the past decades, RNA viruses have been threatened people’s health and led to global health emergencies. Significant progress has been made in diagnostic methods and antiviral therapeutics for combating RNA viruses. ELISA and RT-qPCR are reliable methods to detect RNA viruses, but they suffer from time-consuming procedures and limited sensitivities. Vaccines are effective to prevent virus infection and drugs are useful for antiviral treatment, while both need a relatively long research and development cycle. In recent years, CRISPR-based gene editing and modifying tools have been expanded rapidly. In particular, the CRISPR-Cas13 system stands out from the CRISPR-Cas family due to its accurate RNA-targeting ability, which makes it a promising tool for RNA virus diagnosis and therapy. Here, we review the current applications of the CRISPR-Cas13 system against RNA viruses, from diagnostics to therapeutics, and use some medically important RNA viruses such as SARS-CoV-2, dengue virus, and HIV-1 as examples to demonstrate the great potential of the CRISPR-Cas13 system.
Collapse
|
11
|
Chen XF, Zhao X, Yang Z. Aptasensors for the detection of infectious pathogens: design strategies and point-of-care testing. Mikrochim Acta 2022; 189:443. [PMID: 36350388 PMCID: PMC9643942 DOI: 10.1007/s00604-022-05533-w] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2022] [Accepted: 10/10/2022] [Indexed: 11/11/2022]
Abstract
The epidemic of infectious diseases caused by contagious pathogens is a life-threatening hazard to the entire human population worldwide. A timely and accurate diagnosis is the critical link in the fight against infectious diseases. Aptamer-based biosensors, the so-called aptasensors, employ nucleic acid aptamers as bio-receptors for the recognition of target pathogens of interest. This review focuses on the design strategies as well as state-of-the-art technologies of aptasensor-based diagnostics for infectious pathogens (mainly bacteria and viruses), covering the utilization of three major signal transducers, the employment of aptamers as recognition moieties, the construction of versatile biosensing platforms (mostly micro and nanomaterial-based), innovated reporting mechanisms, and signal enhancement approaches. Advanced point-of-care testing (POCT) for infectious disease diagnostics are also discussed highlighting some representative ready-to-use devices to address the urgent needs of currently prevalent coronavirus disease 2019 (COVID-19). Pressing issues in aptamer-based technology and some future perspectives of aptasensors are provided for the implementation of aptasensor-based diagnostics into practical application.
Collapse
Affiliation(s)
- Xiao-Fei Chen
- Guangdong Provincial Key Laboratory of Chemical Measurement and Emergency Test Technology, Institute of Analysis, Guangdong Academy of Sciences (China National Analytical Center, Guangzhou), Guangzhou, 510070, People's Republic of China
| | - Xin Zhao
- Guangdong Provincial Key Laboratory of Chemical Measurement and Emergency Test Technology, Institute of Analysis, Guangdong Academy of Sciences (China National Analytical Center, Guangzhou), Guangzhou, 510070, People's Republic of China.
| | - Zifeng Yang
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, People's Republic of China.
- Guangzhou Laboratory, Guangzhou, 510320, People's Republic of China.
- Guangzhou Key Laboratory for Clinical Rapid Diagnosis and Early Warning of Infectious Diseases, Guangzhou, 510005, People's Republic of China.
| |
Collapse
|